Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309915 · ClinicalTrials.gov registry record · Phase 1
A Study of STP707 Administered by IV in Healthy Subjects
A Phase 1 study, sponsored by Sirnaomics.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT05309915 is a Phase 1 study that has completed, run by Sirnaomics. The registered enrollment target is 20 participants.
The verdict
NCT05309915, a Phase 1 study, has completed, sponsored by Sirnaomics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Single center study, randomized, to evaluate safety, tolerability, PK of single ascending dose of STP707 when administered by IV infusion in healthy subjects.
Interventions
- DRUG STP707
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-02-28 |
| Est. Completion | 2022-08-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05309915
The ClinicalTrials.gov registry entry for NCT05309915 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sirnaomics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which STP707 is the first listed.
NCT05309915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05309915 about?
NCT05309915 is a clinical study titled "A Study of STP707 Administered by IV in Healthy Subjects". Single center study, randomized, to evaluate safety, tolerability, PK of single ascending dose of STP707 when administered by IV infusion in healthy subjects.
What is the current status of trial NCT05309915?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2022-02-28. Estimated completion is 2022-08-30.
What interventions are being tested in trial NCT05309915?
The interventions under investigation include: STP707 (DRUG).
Who is sponsoring clinical trial NCT05309915?
This trial is sponsored by Sirnaomics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.